Novasep, a supplier of life-sciences manufacturing solutions, and its partner Nilsan Nishotech Systems, a process engineering specialist in India, announced the commissioning of a continuous chromatography Varicol system at Laurus Labs, an API manufacturer based in India.
Novasep, a supplier of life-sciences manufacturing solutions, and its partner Nilsan Nishotech Systems, a process engineering specialist in India, announced the commissioning of a continuous chromatography Varicol system at Laurus Labs, an API manufacturer based in India.
This is the first time Laurus Labs will use a continuous chromatography system at multi-ton scale to obtain high productivity and cost-efficient chiral molecule separation.
Varicol continuous chromatography is used to separate enantiomers from racemic mixtures. A key feature is the solvent recycling unit associated with the chromatography system enabling the process to exhibit low solvent consumption (more than 99.9% solvent recovery).
According to the press release, Novasep’s Varicol is capable of achieving separation of 500 kg per day in Laurus Labs’ production of API. Prior to the installation, Novasep conducted a feasibility study at its R&D laboratory in Pompey, France, to evaluate the continuous process on a small-scale.
Source: Novasep
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
May 14th 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.